RDY - Dr. Reddy's Laboratories Limited

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in INR. All numbers in thousands
Breakdown
ttm
3/30/2019
3/30/2018
3/30/2017
3/30/2016
Total Revenue
165,110,000
153,851,000
142,028,000
140,809,000
154,708,000
Cost of Revenue
75,826,000
70,421,000
65,724,000
62,453,000
62,427,000
Gross Profit
89,284,000
83,430,000
76,304,000
78,356,000
92,281,000
Operating Expenses
Research Development
14,601,000
15,607,000
18,265,000
19,551,000
17,834,000
Selling General and Administrative
53,254,000
48,890,000
46,910,000
46,372,000
45,702,000
Total Operating Expenses
64,008,000
64,162,000
64,629,000
64,984,000
62,821,000
Operating Income or Loss
25,276,000
19,268,000
11,675,000
13,372,000
29,460,000
Interest Expense
1,087,000
889,000
788,000
634,000
826,000
Total Other Income/Expenses Net
2,716,000
3,294,000
2,914,000
1,357,000
-2,893,000
Income Before Tax
27,820,000
22,443,000
14,341,000
14,653,000
27,140,000
Income Tax Expense
1,071,000
3,648,000
4,535,000
2,614,000
7,127,000
Income from Continuing Operations
26,749,000
18,795,000
9,806,000
12,039,000
20,013,000
Net Income
26,749,000
18,795,000
9,806,000
12,039,000
20,013,000
Net Income available to common shareholders
26,749,000
18,795,000
9,806,000
12,039,000
20,013,000
Reported EPS
Basic
-
113.28
59.13
72.24
117.30
Diluted
-
113.09
59.00
72.09
117.00
Weighted average shares outstanding
Basic
-
165,914
165,845
166,649
170,608
Diluted
-
166,193
166,186
166,998
171,051
EBITDA
-
35,522,000
26,839,000
26,564,000
38,216,000